Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation
GS-9669 is a non-nucleos(t)ide inhibitor (NNI) binding to the thumb site II of the Hepatitis C virus (HCV) NS5B polymerase and has advanced into phase II trials. To clarify the drug resistance mechanisms of GS-9669 caused by M423T/I/V, L419M, R422K, and I482L mutations of NS5B polymerase (GT1b) and...
Main Authors: | Di Han, Huiqun Wang, Baerlike Wujieti, Beibei Zhang, Wei Cui, Bo-Zhen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037021001380 |
Similar Items
-
Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients
by: Mahrou Sadri, et al.
Published: (2015-02-01) -
Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine
by: Changyuan Yu, et al.
Published: (2012-03-01) -
Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach
by: Dario Akaberi, et al.
Published: (2018-01-01) -
Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
by: Megan H. Powdrill, et al.
Published: (2010-09-01) -
Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
by: Jaspe Rossana C, et al.
Published: (2012-09-01)